Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia
Journal of Cell Biology · 2025
DOI: 10.1083/jcb.202504010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2025. Verfasst von Alfred C O Vertegaal. Beteiligte Einrichtung: Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Ubiquitin, Small Ubiquitin-Related Modifier Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this issue, Jaffray and colleagues (https://doi.org/10.1083/jcb.202407133) detail the molecular machinery required to degrade the oncogene PML in response to arsenic treatment. Different posttranslational modifiers team up: ubiquitin, SUMO1, and -2/3, linked by the SUMO-targeted ubiquitin ligases TOPORS and RNF4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.
ORCID-Profile: Alfred C O Vertegaal
Zitieren
APA
Vertegaal, A. C. O. (2025). Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia. Journal of Cell Biology. https://doi.org/10.1083/jcb.202504010
Vancouver
Vertegaal ACO. Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia. Journal of Cell Biology. 2025. doi:10.1083/jcb.202504010
BibTeX
@article{Vertegaal2025,
author = {Vertegaal, Alfred C O},
title = {Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia},
journal = {Journal of Cell Biology},
year = {2025},
doi = {10.1083/jcb.202504010}
}
EUVIMED